Medozons
2020-04-21 20:00

Follow-up to the preliminary results about the systemic use of O2/O3 in the treatment of COVID-19



Follow-up to the preliminary results about use of sistemic of O2/O3 in the treatment of Novel Coronavirus Pneumonia (COVID-19).


Date and Version No:6 — 18/04/2020

Download the original document



Security alert: MAH volume > 100 mL // Risk of thrombus in COVID-19 + Patients Emerging evidence shows that severe coronavirus disease 2019 (COVID-19) can be complicated with coagulopathy namely disseminated intravascular coagulation. If your protocol includes MAH use blood volume < 100 mL, use d-dimer as biomarker of potential coagulopathy.
All news Latest news